Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach

Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach

Abstract This multicenter clinical study was aimed at conducting a targeted pharmacogenomic association analysis of residual on‐clopidogrel platelet reactivity in 474 Caribbean Hispanic patients. Platelet reactivity was measured using the VerifyNow P2Y12 assay and clopidogrel resistance was defined...

Full description

Bibliographic Details
Main Authors:	Jorge Duconge, Ednalise Santiago, Dagmar F. Hernandez‐Suarez, Mariangeli Moneró, Andrés López‐Reyes, Marines Rosario, Jessicca Y. Renta, Pablo González, Laura Ileana Fernández‐Morales, Luis Antonio Vélez‐Figueroa, Orlando Arce, Frances Marín‐Maldonado, Héctor Nuñez, Kyle Melin, Stuart A. Scott, Gualberto Ruaño
Format:	Article
Language:	English
Published:	Wiley 2021-11-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.13124

Similar Items

331 A Machine Learning-based Pharmacogenomic Association Study of Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic Patients on Clopidogrel
by: Luis A. Rosario Arroyo, et al.
Published: (2022-04-01)

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.
by: Jorge Duconge, et al.
Published: (2016-01-01)

2042 CYP2C19*2 and PON1 Q192R polymorphisms are associated with platelet reactivity to clopidogrel in Puerto Rican Hispanics with cardiovascular disease
by: Dagmar F. H. Suarez, et al.
Published: (2018-06-01)

Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population
by: Hernandez-Suarez DF, et al.
Published: (2018-06-01)

Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study
by: Karla Claudio-Campos, et al.
Published: (2017-06-01)

4423 Impact of Gender on High On-Treatment Platelet Reactivity (HPR) and Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic patients using Clopidogrel
by: Hector Jose Nunez Medina, et al.
Published: (2020-06-01)

Non-Random Enrichment of Single-Nucleotide Polymorphisms Associated with Clopidogrel Resistance within Risk Loci Linked to the Severity of Underlying Cardiovascular Diseases: The Role of Admixture
by: Mariangeli Monero-Paredes, et al.
Published: (2023-09-01)

Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
by: Chris Terpening
Published: (2010-12-01)

Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
by: Chris Terpening
Published: (2010-01-01)

Editorial: Pharmacogenomics in neglected populations
by: Mariana R. Botton, et al.
Published: (2022-11-01)

Polygenic risk scores in pharmacogenomics: opportunities and challenges—a mini review
by: Aurélien Simona, et al.
Published: (2023-06-01)

Skeletal Microstructure in Caribbean Hispanic Women
by: Sanchita Agarwal, et al.
Published: (2023-05-01)

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
by: Anthi Maslarinou, et al.
Published: (2023-05-01)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
by: Abiel Roche-Lima, et al.
Published: (2020-01-01)

Polygenic risk scores and kidney traits in the Hispanic/Latino population: The Hispanic Community Health Study/Study of Latinos
by: Laura Y. Zhou, et al.
Published: (2023-04-01)

Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods
by: Song Zhai, et al.
Published: (2022-09-01)

Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine
by: Sherry-Ann Brown, et al.
Published: (2018-01-01)

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
by: Kisor DF, et al.
Published: (2021-05-01)

Pertussis in Latin America and the Hispanic Caribbean: a systematic review
by: Angela Gentile, et al.
Published: (2019-08-01)

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
by: Calderon-Ospina CA, et al.
Published: (2020-03-01)

Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics.
by: Caren E Smith, et al.
Published: (2009-01-01)

2220
by: Kyle Melin, et al.
Published: (2017-09-01)

Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study
by: Christian Tagwerker, et al.
Published: (2022-05-01)

Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
by: Xiaoguang Zhang, et al.
Published: (2023-01-01)

An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean
by: Aimeé Salas-Hernández, et al.
Published: (2023-05-01)

3321 European Ancestry as a Risk Factor for Atrial Fibrillation in Puerto Rican Hispanics
by: Ariel Gonzalez-Cordero, et al.
Published: (2019-03-01)

THE PRICE OF "COARTACIÓN" IN THE HISPANIC CARIBBEAN: HOW MUCH FREEDOM DOES THE MASTER OWE TO THE SLAVE?
by: Claudia Varella
Published: (2012-06-01)

The Caribbean-Hispanic Alzheimer's disease brain transcriptome reveals ancestry-specific disease mechanisms
by: Daniel Felsky, et al.
Published: (2023-01-01)

Book Review: Racialized Visions Haiti and the Hispanic Caribbean by Vanessa K. Valdés (2020)
by: M. Stephanie Chancy
Published: (2023-01-01)

New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model
by: Karine Rodríguez-Fernández, et al.
Published: (2024-01-01)

Pharmacogenomics /
by: Kalow, Werner, et al.
Published: (2005)

MEF2C Common Genetic Variation Is Associated With Different Aspects of Cognition in Non-Hispanic White and Caribbean Hispanic Non-demented Older Adults
by: Preeti Sunderaraman, et al.
Published: (2021-07-01)

Rates and factors associated with falls in older European Americans, Afro-Caribbeans, African-Americans, and Hispanics
by: Vieira ER, et al.
Published: (2015-10-01)

Counternarratives of Nationalist Anti-Black Images: Normalizing and Extolling Blackness in Contemporary Art of the Hispanic Caribbean
by: Liza Girgis
Published: (2022-02-01)

Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient
by: Dagmar F. Hernandez-Suarez MD, et al.
Published: (2016-12-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
by: Christian Tagwerker, et al.
Published: (2022-05-01)

Pharmacogenomics of Antibiotics
by: Gabriele Stocco, et al.
Published: (2020-08-01)

2529
by: Dagmar Fredy Hernandez Suarez, et al.
Published: (2017-09-01)

Pharmacogenomics of Cardiovascular Pharmacology: Pharmacogenomic Network of Cardiovascular Disease Models
by: Toshio Tanaka, et al.
Published: (2008-01-01)